| 查看: 1034 | 回复: 5 | |||
[交流]
单一和多重过敏呼吸道变应性疾病儿童屋尘螨舌下特异性免疫治疗的疗效和安全性 已有5人参与
|
|
Background: The efficacy of single-allergen-specific immunotherapy in polysensitized subjects is a matter of debate. This study aimed to investigate the efficacy of house dust mite (HDM) sublingual immunotherapy (SLIT) in monosensitized and polysensitized children. Methods: A total of 112 children, aged 4 to 13 years old, with HDM-induced respiratory allergic diseases were allocated to a monosensitized group (n = 56) or a polysensitized group (n = 56). Both groups were treated by standard pharmacotherapy and SLIT with Dermatophagoides farinae (American HDM) extracts for 52 weeks. Symptoms, medications, visual analogue scale (VAS), and presence of adverse events (AEs) were assessed once a month. Skinprick test (SPT) was done before and aer treatment. After treatment, subjects in the polysensitized group who completed the study were further analyzed as subgroup 1 (n=20) and subgroup 2 (n=15) according to the number of coexisting allergens. Results: Forty-one subjects in the monosensitized group and 35 subjects in the polysensitized group completed the study. The global clinical parameters had significantly improved after treatment, with no significant difference between the monosensitized and polysensitized group throughout this period (all p > 0.05). The comparison among the monosensitized group, subgroup 1, and subgroup 2 indicated that there was no significant difference in symptoms scores and VAS at each scheduled follow-up visit. Therewas also no significant difference in total medications score (TMS) in the monosensitized group, subgroup 1, and subgroup 2 after week 24 (all p > 0.05). No severe systemic AEs were reported. Conclusion: No significant difference was observed in the clinical effects of HDM SLIT between polysensitized and monosensitized children with respiratory allergic diseases. |
回复此楼» 猜你喜欢
求助台湾地区新型专利《复合量子氢之共振产生装置》案号：110204608授权说明书
已经有0人回复
-
2022年上海交通大学医学院考博
已经有1人回复
-
中药学论文润色/翻译怎么收费?
已经有78人回复
-
论文发表求助
已经有5人回复
-
投稿参考格式等修改求助
已经有1人回复
-
HYTOmedicine反馈意见修改参考文献格式
已经有0人回复
-
科研助理/24-25年博士申请 纳米递药
已经有16人回复
-
中药材速查轻图典.邱秀丽.全彩版
已经有2人回复
-
中医316，求调剂，接受跨专业
已经有0人回复
-
医疗质量安全核心制度落实情况监测指标（2025年版）
已经有0人回复
★
小木虫: 金币+0.5, 给个红包，谢谢回帖
小木虫: 金币+0.5, 给个红包，谢谢回帖
|
本帖内容被屏蔽 |
2楼2020-01-02 10:03:34
★
小木虫: 金币+0.5, 给个红包，谢谢回帖
小木虫: 金币+0.5, 给个红包，谢谢回帖
|
本帖内容被屏蔽 |
3楼2020-01-03 11:31:25
★
小木虫: 金币+0.5, 给个红包，谢谢回帖
小木虫: 金币+0.5, 给个红包，谢谢回帖
|
本帖内容被屏蔽 |
4楼2020-01-04 15:16:52
★
小木虫: 金币+0.5, 给个红包，谢谢回帖
小木虫: 金币+0.5, 给个红包，谢谢回帖
|
本帖内容被屏蔽 |
5楼2020-01-07 11:35:08
★
小木虫: 金币+0.5, 给个红包，谢谢回帖
小木虫: 金币+0.5, 给个红包，谢谢回帖
|
本帖内容被屏蔽 |
6楼2020-01-09 11:27:18
